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THE PROGNOSIS IN CANCER OF THE KIDNEY
ROBERT J. FETZ, M . D . ' ^ '

In the past quarter of a century, advances in anesthesiology, the ready availability
of whole blood and blood substitutes and the discovery of the broad-spectrum antibiotics have enabled many surgeons to become increasingly radical in their approach
to the cancer problem. Operative morbidity and mortality have been kept at a minimum
as earlier diagnosis and the new and more radical surgical techniques have increased
the percentage of five and ten year survivals. Unfortunately this is not true in the
case of renal cancer. Even a cursory comparison of the survival from renal malignancy
now, as compared with the earlier era, reveals little change. Cancer of the kidney
remains an enigma and a chaflenge to the profession.
By far the most important and frequent type of renal cancer is the hypernephroma
or clear cell carcinoma. Of 105 renal malignancies seen in this hospital between 1924
and 1954 seventy-eight percent were of the clear cell variety. This form of renal cancer
has a predilection for the male and the right side, being about twice as frequent in
this sex and kidney. The over-all average age of occurrence is fifty-five years. Ninety
percent of cases occur in the fourth to the seventh decade. (Figure 1.). Almost all
exceptions to this were in the female.
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Age distribution by sex of cancer of the kidney (clear cell variety)
Unfortunately medical texts emphasize all too infrequently that the characteristic
triad of hematuria, mass and pain are relatively late symptoms of the disease process.
Comparison of the signs and symptoms in those cases considered clinically inoperable
as opposed to those considered operable and found to be without evidence of spread
at surgery, reveals a marked predominance of hematuria in the latter group and
an increased frequency of vague complaints (weakness, weight loss, anorexia etc.)
and fever in the inoperable group. (Table 1.) Figure 2 lists the most commons symptoms
and signs seen in renal cancer and compares their frequency with survival. The occurrence of hematuria, per se, is of no prognostic significance. It may occur at any time
in the course of the disease. I f the patient is so fortuitous as to have his initial lesion
adjacent to the renal collecting system hematuria may occur early and be a life saving
"'Resident, Division of Urology.
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Table 1
Comparison of Symptomatology
Symptom

Inoperable (16)

Hematuria
Edema
Mass
Tenderness
Pain
Vague Sx
Fever

31.3%
25%
43.7%
6.3%
56.3%
37.5%
18.7%

5
4
7
1
9
6
3

Operable (28)
( N o Extension)
75%
21
2
7.2%
61.2%
17
10.8%
3
61.2%
17
7.2%
2
3.6%
1
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Figure 2
The most frequent signs and symptoms observed in cancer of the
kidney are listed. Their frequency of occurrence as compared
with survival is graphically illustrated.
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Figure 3
Comparison of Operable and Inoperable Cases with respect to
the relative delay in patient-physician contact.
sign. Many patients, however, delay medical consultation despite this "red light of
trouble." The average patient is .symptomatic eight months prior to seeking the advice
of his physician. Sixty percent of those considered operable when first seen had symptoms
three months or less, whereas those considered inoperable averaged 15 months.
(Figure 3.)
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Clear cefl carcinoma characteristically metastasizes by the hematogenous rather
than the lymphogenous route. Many authors have stated however, that inasmuch as the
early lesion is encapsulated metastasis occurs late. A glance at survival rates makes
such statements appear unfounded. The hypernephromata are capricious to say the
least. There is marked variation in the malignancy of one growth as compared to
another. Reports of prolonged survival after resection of solitary metastasis to the lung or
thyroid are not uncommon, nor is it infrequent that we read of death from carcinomatosis after ten or twelve years freedom from the cflnical evidence of cancer.
The sites of metastasis may be classified into two groups, local and terminal.
The local sites (Table 2) represent those areas found involved at laparotomy when
clinically the pa.tient appeared curable. The terminal sites (Table 3) are those areas
in which metastases show predilection as the disease progresses.
Table 2
Sites of Local Metastasis
Renal pedicle and/or Vena Cava
Local musculature
Peri-renal fat
Peritoneum
Abdominal viscera (bowel)
Diaphragm
Adrenal (ipsilateral)
Ureter (ipsilateral)
Regional nodes

Table 3
Sites of Terminal Metastasis
-8
7
-6
-4
-4
-3
-2
-1
-1

Lung
Nodes—regional and distant
Liver
Bone
Abdominal viscera
Local
Skin
Brain
Thyroid

19
17
17
15
- .- 11
9
7
4
3

More than 50% of local extension lies in three spheres—namely involvement of
the renal pedicle and vessels, adjacent musculature and peri-renal adipose tissue. Extension in these areas is highly suggestive that vascular metastases have already occurred
and that the prognosis must be guarded. The predominance of pulmonary, hepatic
and skeletal metastases is in accord with the findings of other writers. The occurrence
of spread to the skin and thyroid should be noted. One case in this series underwent
thyroidectomy five and one-half years postoperatively for a solitary metastasis to
that gland and is now alive and well one year later. As a general rule once metastatic
disease is found, whether local or terminal, the demise of the patient may be expected
within one year. The majority die within six months.
In this series of 82 proven cases of renal cancer, disregarding clinical and surgical
operability, survival averaged 26 months. I f the patient had "terminal" type metastases
on his initial admission he was classified as "inoperable." Sixteen patients were so
listed. One patient was lost to follow-up. Of the remaining 15 cases 10 were dead
wflhin six months and only 2 lived beyond one year. (14 and 15 months respectively.)
(Figure 4.)
A n attempt was made to estabflsh statistics for 5 year survivals from those cases
flsted as operable when initially seen. Thirty-eight of the remaining sixty-six cases
were operated no later than 1949 and were used as the basis for these figures. These
were divided into two groups depending on the findings at surgery. Twenty-one had
no evidence of local extension. Nine of these patients (42%) lived beyond the fifth
year. Six are still alive, two of which are beyond their tenth year. Of the three patients
that died after their fifth postoperative year, two died of carcinoma and one of heart
disease. Of those that are alive all are free of cancer except one. This patient had a
total thyroidectomy for a solitary metastasis to that gland one year ago.
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Figure 4
Survival of Inoperable Cases
Note that about 90% were dead within 1 year, but that the greatest mortality
occurred within the first 6 months.
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Figure 5
An analysis of the 5 year survival rate
in 38 cases of proven hypernephromas subjected to nephrectomy, 21 of which had
no evidence of spread at surgery, 17 had
gross evidence of extension.
Seventeen patients classified as operable were found to have evidence of local extension at the time of nephrectomy. Eight of these were dead within one year after surgery. Only three patients in this group lived beyond the fifth year. Two are alive, one
with carcinomatosis and one free of tumor. The third patient died of tumor after the
10th year. Figure 5 is a graphic comparison of the effect of local extension on survival.
Discussion:
It is apparent from the facts presented in this study that the weakest links in the
management of renal carcinoma are those concerned with the problem of earlier
diagnosis and more prompt patient-physician contact. The lack of early symptomatology
makes it apparent that in the future the surgeon will have to rely on some form of
diagnostic aid. A practical screening study of some form is urgently needed. Papanicolaou smears of the urinary sediment are helpful but are not the answer. Ideal localization of the lesion is required if exfoliated cells are to appear in the urine. Intravenous
pyelography may eventually be used as an over-all screening device. In the interim,
the public must be educated to accept periodic physical examination as a necessity,
not as a luxury, and to be prompt in fully discussing new symptomatology with their
physicians, especially when in the cancer age groups. Physicians also must be taught
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to become increasingly aware of the cancer problem, more adroit in its early diagnosis
and more radical in its treatment.
Summary:
A clinical study of 82 proven cases of clear cell carcinoma is presented.
The only criterion of prognostic significance is the presence or absence of metastases, local or terminal.
The average survival after diagnosis is 26 months.
Eighty-five percent of inoperable cases are dead within one year.
The 5 year survival in cases undergoing nephrectomy in the absence of local
extension is 43%
The 5 year survival in cases undergoing nephrectomy in the presence of local
extension is 17.6%.
The need for earlier diagnosis and a practical screening device is mentioned.
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